Insight

Apr 9, 2024, 09:03

Giannis Mountzios: The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC

Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital in Athens, shared a post on X:

“The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC.

Very elegant work in the New England Journal of Medicine by Benjamin Besse and colleagues exemplifying the value of post-marketing pragmatic re-assessment of new TKIs in NSCLC. Be aware!”

View the additional information.
Source: Giannis Mountzios/X

Air force General Hospital in Athens Benjamin Besse cancer Giannis Mountzios New England Journal of Medicine non small cell lung cancer NSCLC OncoDaily Oncology Selpercatinib TKIs

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage